Chemoinformaics analysis of (25R)-Spirost-5-en-3beta-ol acetate
| Molecular Weight | 456.667 | nRot | 1 |
| Heavy Atom Molecular Weight | 412.315 | nRig | 31 |
| Exact Molecular Weight | 456.324 | nRing | 6 |
| Solubility: LogS | -6.13 | nHRing | 2 |
| Solubility: LogP | 5.836 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 80.9769 |
| nHD | 0 | BPOL | 50.2171 |
| QED | 0.344 |
| Synth | 5.264 |
| Natural Product Likeliness | 3.118 |
| NR-PPAR-gamma | 0.032 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.95 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.823 |
| MDCK | 0.0000366 |
| BBB | 0.657 |
| PPB | 0.98353 |
| VDSS | 1.634 |
| FU | 0.0184771 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.143 |
| CYP2c19-inh | 0.047 |
| CYP2c19-sub | 0.926 |
| CYP2c9-inh | 0.106 |
| CYP2c9-sub | 0.094 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.739 |
| CYP3a4-inh | 0.247 |
| CYP3a4-sub | 0.414 |
| CL | 19.18 |
| T12 | 0.019 |
| hERG | 0.017 |
| Ames | 0.044 |
| ROA | 0.675 |
| SkinSen | 0.055 |
| Carcinogencity | 0.261 |
| EI | 0.009 |
| Respiratory | 0.542 |
| NR-Aromatase | 0.261 |
| Antiviral | Yes |
| Prediction | 0.721523 |